Effect of light and heat on the stability of montelukast in solution and in its solid state

被引:51
作者
Al Omari, Mahmoud M. [1 ]
Zoubi, Rufaida M. [1 ]
Hasan, Enas I. [1 ]
Khader, Tariq Z. [1 ]
Badwan, Adnan A. [1 ]
机构
[1] Jordanian Pharmaceut Manufact Co, Naur, Jordan
关键词
montelukast; photodegradation; chemical stability; oxidation; HPLC;
D O I
10.1016/j.jpba.2007.07.014
中图分类号
O65 [分析化学];
学科分类号
070302 [分析化学]; 081704 [应用化学];
摘要
The chemical stability of montelukast (Monte) in solution and in its solid state was studied. A simultaneous measurement of Monte and its degradation products was determined using a selective HPLC method. The HPLC system comprised a reversed phase column (C 18) as the stationary phase and a mixture of ammonium acetate buffer of pH 3.5 and methanol (15:85 v/v) as the mobile phase. The UV detection was conducted at 254 run. Monte in solution showed instability when exposed to light leading to the formation of its cis-isomer as the major photoproduct. The rate of photodegradation of Monte in solution exposed to various light sources increases in the order of; sodium < neon < tungsten < daylight < UV (254 nm). The extent of photodegradation was influenced by solvent type, where Monte was found to be most stable in 70% methanol. In solid state, Monte showed more than 20% decrease in its potency after exposure to daylight for I week. Also unpacked Monte chewable tablets, exposed to daylight for 2 weeks, showed a decrease of about 10% with the formation of Monte S-oxide as a major photoproduct. On the other hand, Monte film-coated tablets either unpacked or in its immediate pack showed excellent stability under the same condition. The thermal stress testing study of Monte in solutions at 65 degrees C showed that it is highly stable in NaOH solution, while it degrades rapidly in both acidic and H2O2 solutions. The major degradation product in the latter solvent was Monte S-oxide and it was also detected as a major degradation product in Monte tablet dosage form during the incubation at 40 degrees C/75% RH for 6 months. Findings of this study have helped to understand the stability behavior of Monte and to establish the critical parameters, which may affect its analysis and manufacturing activities. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:465 / 471
页数:7
相关论文
共 16 条
[1]
ALSARRA IA, 2004, SAUDI PHARM J, V12, P136
[2]
[Anonymous], [No title captured]
[3]
ARISON BH, 1999, Patent No. 5952347
[4]
Bhupathy M., 1995, [No title captured], Patent No. [0737186, EP 0737186]
[5]
Synthesis of Montelukast (MK-0476) metabolic oxidation products [J].
Dufresne, C ;
Gallant, M ;
Gareau, Y ;
Ruel, R ;
Trimble, L ;
Labelle, M .
JOURNAL OF ORGANIC CHEMISTRY, 1996, 61 (24) :8518-8525
[6]
Application of pressurized liquid extraction technology to pharmaceutical solid dosage form analysis [J].
Hoang, TH ;
Farkas, R ;
Wells, C ;
McClintock, S ;
Di Maso, M .
JOURNAL OF CHROMATOGRAPHY A, 2002, 968 (1-2) :257-261
[7]
*ICH, 1996, ICH TOP Q2B VAL AN P
[8]
Establishment of a kinetic model for urocanic acid photoisomerization [J].
Laihia, JK ;
Lemmetyinen, H ;
Pasanen, P ;
Jansen, CT .
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 1996, 33 (03) :211-217
[9]
Determination of montelukast (MK-0476) and its S-enantiomer in human plasma by stereoselective high-performance liquid chromatography with column-switching [J].
Liu, LD ;
Cheng, HY ;
Zhao, JJ ;
Rogers, JD .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1997, 15 (05) :631-638
[10]
Simultaneous determination of montelukast and loratadine by HPLC and derivative spectrophotometric methods [J].
Radhakrishna, T ;
Narasaraju, A ;
Ramakrishna, M ;
Satyanarayana, A .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2003, 31 (02) :359-368